课题基金 / 基金详情

STUDIES OF NEUROTRANSMITTER SYSTEMS FUNCTION IN SCHIZOPHRENIA/PSYCHOSIS

STUDIES OF NEUROTRANSMITTER SYSTEMS FUNCTION IN SCHIZOPHRENIA/PSYCHOSIS
精神分裂症/精神病中神经递质系统功能的研究
批准号：
3766281
负责人：
JAMES W MAAS
金额：
$0.0万
依托单位：
UNIVERSITY OF TEXAS HLTH SCIENCE CENTER
依托单位国家：
美国
项目类别：
财政年份：
--
资助国家：
美国
项目状态：
未结题
起止时间：
至
来源：
https://reporter.nih.gov/project-details/3766281
关键词：
adrenergic agents clonidine human subject human therapy evaluation mental disorder chemotherapy neuropharmacology norepinephrine schizophrenia

项目摘要

项目成果

JAMES W MAAS的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This study will use clonidine, a norepinephrine receptor agonist, both as a challenge and treatment agent in patients with schizophrenia to decrease the production of norepinephrine and its metabolites and determine if this reduction is associated with decrements in biological markers of norepinephrine system activity and improvement in the patients' clinical state.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DEBRISOQUIN AS AN AGENT FOR THE STUDY OF PSYCHOTIC STATE
DEBRISOQUIN AS AN AGENT FOR THE STUDY OF PSYCHOTIC STATE
DEBRISOQUIN AS AN AGENT FOR STUDY OF PSYCHOTIC STATES
DEBRISOQUIN AS AN AGENT FOR THE STDY OF PSYCHOTIC STATES
海外基金